JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Clinical Pathology 2007;60:1313-1320; doi:10.1136/jcp.2006.040626
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wells, C A
Right arrow Articles by El-Ayat, G A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wells, C A
Right arrow Articles by El-Ayat, G A
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Breast Cancer

BREAST PATHOLOGY

Non-operative breast pathology: apocrine lesions

C A Wells, G A El-Ayat

St Bartholomew’s Hospital, London, UK

Correspondence to:
Dr C A Wells, 4th Floor, Pathology Block, St Bartholomew’s Hospital, West Smithfield, London EC1A 7BE, UK; c.a.wells{at}qmul.ac.uk

Apocrine metaplasia is a very common finding in the female breast after the age of 25. It is so common that many people regard it as a normal component of the breast. This, however, is only really the case in apocrine sweat glands of the axilla and in the peri-areolar apocrine glands. The apocrine cell does, however, contribute to a number of different breast lesions, some of which are very taxing diagnostically; apocrine variants of both in-situ and invasive cancer are encountered. This review considers the common apocrine metaplastic lesions seen in fibrocystic change as well as apocrine adenoma, apocrine change within sclerosing adenosis, atypical apocrine lesions and apocrine malignancies.


Abbreviations: ADH, atypical ductal hyperplasia; APM, apocrine metaplasia; AR, androgen receptor; DCIS, ductal carcinoma in-situ; ER, oestrogen receptor; GCDFP, gross cystic disease fluid protein; NST, no special type; PAC, papillary apocrine change; PR, progesterone receptor

Keywords: apocrine; metaplasia; breast; atypical; adenosis; apocrine carcinoma




This article has been cited by other articles:


Home page
Mol. Cell. ProteomicsHome page
J. E. Celis, P. Gromov, T. Cabezon, J. M. A. Moreira, E. Friis, K. Jirstrom, A. Llombart-Bosch, V. Timmermans-Wielenga, F. Rank, and I. Gromova
15-Prostaglandin Dehydrogenase Expression Alone or in Combination with ACSM1 Defines a Subgroup of the Apocrine Molecular Subtype of Breast Carcinoma
Mol. Cell. Proteomics, October 1, 2008; 7(10): 1795 - 1809.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
S E Pinder and J S Reis-Filho
Non-operative breast pathology
J. Clin. Pathol., December 1, 2007; 60(12): 1297 - 1299.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.